Analysis by Optimly for Optimly AI Visibility, in the Optimly AI Brand Index. This Business Profile tracks the Brand Authority Index and supporting AI visibility evidence. Last analyzed June 26, 2026.
Takara Bio is a leading Japanese biotechnology company focused on developing, manufacturing, and selling reagents and instruments for life science research. They also provide services and products related to gene therapy and cell therapy, including contract development and manufacturing organization (CDMO) services for novel gene and cell therapy products.
Optimly has not yet published enough evidence to assess how often AI assistants recommend Takara Bio.
Optimly has not yet published a supported competitor set for Takara Bio.
Official website: https://takarabio.org/
Last analyzed: June 26, 2026
This Business Profile is published by Optimly in the Optimly AI Brand Index, a public research dataset showing how AI systems describe brands, categories, and competitors. Optimly AI Visibility analyzes sampled buyer-intent responses, cited sources, and public brand information. The Brand Authority Index summarizes answer presence, narrative accuracy, and owned citations where sufficient evidence is available.
If this is your brand, you can claim this profile to verify its contents and correct what AI models say about you: Claim this profile